Małecka-Panas E - Search Results

1

p16 gene mutations in Barrett's esophagus in gastric metaplasia - intestinal metaplasia - dysplasia - adenocarcinoma sequence.

Mokrowiecka A, Wierzchniewska-Ławska A, Smolarz B, Romanowicz-Makowska H, Małecka-Panas E. Mokrowiecka A, et al. Adv Med Sci. 2012 Jun 1;57(1):71-6. doi: 10.2478/v10039-012-0003-0. Adv Med Sci. 2012. PMID: 22440936

2

[Assessment of usefulness of anti-Saccharomyces cerevisiae and anti-neutrophil cytoplasmic antibodies in patients with unspecific inflammatory bowel diseases].

Mokrowiecka A, Gasiorowska A, Małecka-Panas E. Mokrowiecka A, et al. Pol Merkur Lekarski. 2004;17 Suppl 1:22-6. Pol Merkur Lekarski. 2004. PMID: 15603341 Polish.

3

Usefulness of p16 and K-ras mutation in pancreatic adenocarcinoma and chronic pancreatitis differential diagnosis.

Talar-Wojnarowska R, Gasiorowska A, Smolarz B, Romanowicz-Makowska H, Strzelczyk J, Janiak A, Kulig A, Malecka-Panas E. Talar-Wojnarowska R, et al. J Physiol Pharmacol. 2004 Jul;55 Suppl 2:129-38. J Physiol Pharmacol. 2004. PMID: 15608367

4

Clinical significance of K-ras and c-erbB-2 mutations in pancreatic adenocarcinoma and chronic pancreatitis.

Talar-Wojnarowska R, Gasiorowska A, Smolarz B, Romanowicz-Makowska H, Strzelczyk J, Janiak A, Kulig A, Malecka-Panas E. Talar-Wojnarowska R, et al. Int J Gastrointest Cancer. 2005;35(1):33-41. doi: 10.1385/IJGC:35:1:033. Int J Gastrointest Cancer. 2005. PMID: 15722572 Clinical Trial.

5

Comparative evaluation of p53 mutation in pancreatic adenocarcinoma and chronic pancreatitis.

Talar-Wojnarowska R, Gasiorowska A, Smolarz B, Romanowicz-Makowskal H, Strzelczyk J, Janiak A, Malecka-Panas E. Talar-Wojnarowska R, et al. Hepatogastroenterology. 2006 Jul-Aug;53(70):608-12. Hepatogastroenterology. 2006. PMID: 16995472

6

[Comparable evaluation of usefulness of traditional methods and polymerase chain reaction technique in detection of Helicobacter pylori infection].

Bak-Romaniszyn L, Smolarz B, Kulig A, Płaneta-Małecka I, Zeman K, Małecka-Panas E. Bak-Romaniszyn L, et al. Pol Merkur Lekarski. 2007 May;22(131):350-3. Pol Merkur Lekarski. 2007. PMID: 17679365 Polish.

7

pANCA and ASCA in the diagnosis of different subtypes of inflammatory bowel disease.

Mokrowiecka A, Gasiorowska A, Malecka-Panas E. Mokrowiecka A, et al. Hepatogastroenterology. 2007 Jul-Aug;54(77):1443-8. Hepatogastroenterology. 2007. PMID: 17708273

8

Clinical significance of interleukin-6 (IL-6) gene polymorphism and IL-6 serum level in pancreatic adenocarcinoma and chronic pancreatitis.

Talar-Wojnarowska R, Gasiorowska A, Smolarz B, Romanowicz-Makowska H, Kulig A, Malecka-Panas E. Talar-Wojnarowska R, et al. Dig Dis Sci. 2009 Mar;54(3):683-9. doi: 10.1007/s10620-008-0390-z. Epub 2008 Jul 26. Dig Dis Sci. 2009. PMID: 18661238

9

Tumor necrosis factor alpha and interferon gamma genes polymorphisms and serum levels in pancreatic adenocarcinoma.

Talar-Wojnarowska R, Gasiorowska A, Smolarz B, Romanowicz-Makowska H, Kulig A, Malecka-Panas E. Talar-Wojnarowska R, et al. Neoplasma. 2009;56(1):56-62. doi: 10.4149/neo_2009_01_56. Neoplasma. 2009. PMID: 19152246

10

Clinical utility of serological markers in inflammatory bowel disease.

Mokrowiecka A, Daniel P, Słomka M, Majak P, Malecka-Panas E. Mokrowiecka A, et al. Hepatogastroenterology. 2009 Jan-Feb;56(89):162-6. Hepatogastroenterology. 2009. PMID: 19453050

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

205 results

Search Page

Filters